| URL | https://www.medtechdive.com/news/abbott-awarded-1b |
| Source | medtechdive.com |
| Date Published | 03/25/2022 |
| Author Name | Greg Slabodkin |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Abbott |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 306 |
| City reshored to: | Orlando |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | rapid COVID-19 antigen tests |
| What domestic positive factors made reshoring more attractive? | Government Incentives |
| Government Incentive dollar amount: | $306 contract, American Rescue Plan Act |